Matisse Capital’s Transmedics TMDX Stock Holding History

Matisse Capital’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,000	Closed	-$785K	–	183
2024 Q3	$785K	Buy	5,000 +2,000	+67%	+$308K	0.38%	83
2024 Q2	$452K	Buy	+3,000	New	+$360K	0.22%	122

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Matisse Capital's TMDX Position: Q4 2024 in Review

Matisse Capital sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 5,000 shares — an estimated $785K sold.

Matisse Capital first reported a position in TMDX in Q2 2024 and held it in 2 quarters. The position peaked at $785K in Q3 2024. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

Matisse Capital reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
Matisse Capital sold 5,000 Transmedics shares in Q4 2024, an estimated $785K.
Matisse Capital first reported a position in Transmedics in Q2 2024 and held it in 2 quarters.
Matisse Capital's Transmedics position peaked at $785K in Q3 2024.
315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on Matisse Capital's 13F filing for Q4 2024, filed 24 Jan 2025.